Independent fund research. Built on SEC filings.

How we research funds

Mutual fund · Large Blend · American Funds (Capital Group)

American Funds Preservation Portfolio Class A (PPVAX)

Ticker PPVAX · Since 2012-05-18 · · Holdings as of Jul 31, 2026

Expense ratio
0.66%$66/yr per $10k
5-yr return
+0.8%annualized
1-yr return
+1.1%as of Dec 2024
Net assets
$1.8Ball share classes
Holdings
2

Bottom line

Is PPVAX a good fund? The bottom line

PPVAX is the Class A share class of American Funds Preservation Portfolio, an actively managed large blend mutual fund from American Funds (Capital Group).

It charges 0.66% — about $66 a year on every $10,000 invested, cheaper than 65% of large blend funds we track.

It returned +1.1% over one year, +0.8% a year over five years, +1.1% a year over ten (as of Dec 31, 2024, per its prospectus).

With $1.8 billion in net assets and 2 holdings, its largest position is Short Term Bond Fund Of America (54.8%) and the top 10 make up 99.7% of the portfolio.

This share class carries a front-end sales charge of up to 2.5%; a no-load class or ETF alternative can avoid it.

What to watch

  • 5-year return in the bottom quarter of its category
  • Concentrated: top 10 holdings are 99.7% of assets
  • Front-end sales load up to 2.5%
  • 12b-1 marketing fee of 0.3% a year

Updated Nov 19, 2026

What PPVAX invests in

The funds investment objective is to provide current income, consistent with preservation of capital.

The fund will attempt to achieve its investment objective by investing in a mix of American Funds fixed income funds. The fund will principally invest in funds that seek current income through investments in bonds or in other fixed income instruments. When determining in which bond funds to invest, the investment adviser will predominately seek exposure to higher quality bonds (rated A- or better or A3 or better by Nationally Recognized Statistical Rating Organizations designated by the funds investment adviser, or unrated but determined by the funds investment adviser to be of equivalent quality) with intermediate to short-term durations. The fund may, however, invest in underlying funds with exposure to lower quality, higher yielding securities rated BBB+ or below and Baa1 or below (including those rated BB+ or below and Ba1 or below) or unrated but determined by the funds investment…

From the fund's prospectus (filed Dec 31, 2025).

PPVAX performance

Average annual total returns
1 yr5 yr10 yr
PPVAX+1.1%+0.8%+1.1%
Large Blend median+13.8%+9.7%+10.9%

Source: Fund prospectus, as of Dec 31, 2024

Full PPVAX performance history →

What PPVAX costs

On a $10,000 investment, PPVAX's 0.66% expense ratio costs about $66 a year. The prospectus estimates $1,052 in total costs over 10 years (assuming 5% annual returns). The median large blend fund charges 0.83%.

See the full PPVAX fee table →

PPVAX top 10 holdings

#Holding% of fund
1Short Term Bond Fund Of America RMMGX54.83%
2Intermediate Bond Fund Of America RBOGX44.84%

Source: SEC Form N-PORT, period ended Jul 31, 2026

The top 10 make up 99.7% of the fund. See all top 25 holdings and asset mix →

Alternatives to PPVAX

More funds like PPVAX →

PPVAX FAQ

What is the expense ratio of PPVAX?
PPVAX's expense ratio is 0.66%, which works out to about $66 a year for every $10,000 invested. The prospectus estimates total costs of $1,052 over 10 years on a $10,000 investment (assuming 5% annual returns).
Is PPVAX a good investment?
It depends on your goals, but the data points to: 5-year return in the bottom quarter of its category; concentrated: top 10 holdings are 99.7% of assets; front-end sales load up to 2.5%; 12b-1 marketing fee of 0.3% a year. This is general information, not personalized advice.
What does PPVAX hold?
PPVAX's largest holdings are Short Term Bond Fund Of America (54.8%), Intermediate Bond Fund Of America (44.8%). It holds 2 positions in total as of Jul 31, 2026 (SEC Form N-PORT).
What is PPVAX's 5-year return?
PPVAX returned +0.8% a year over the five years ending Dec 31, 2024, and +1.1% a year over ten years. Past performance does not guarantee future results.
Does PPVAX have a sales load?
Yes. PPVAX has a maximum front-end sales charge of 2.5%. It may charge a deferred sales charge of up to 0.75% if sold early.
Who manages PPVAX?
PPVAX is offered by American Funds (Capital Group) through American Funds Portfolio Series.